This discovery provides new mechanistic insights into how TRIM24 exerts its oncogenic effects and suggests that targeting TRIM24 or enhancing NRBP1 expression could serve as promising therapeutic strategies for the treatment of gastric cancer. The gene discussed is TRIM24; the disease is gastric cancer.